S.C. Ropharma S.A. (BVB: RPH)

S.C. Ropharma Income Statement

Financials in millions RON. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating Revenue	1,064	1,006	912.74	776.69	716.27	720.21
Other Revenue	123.31	113.83	89.23	111.47	89.58	63.5
Revenue	1,187	1,120	1,002	888.16	805.85	783.71
Revenue Growth (YoY)	10.06%	11.80%	12.81%	10.21%	2.83%	23.18%
Cost of Revenue	916.19	866.05	788.1	686.93	625.55	628.44
Gross Profit	270.69	254.14	213.88	201.23	180.31	155.27
Selling, General & Admin	197.53	184.61	156.95	142.62	124.74	112.05
Other Operating Expenses	25.15	22.86	23.88	18.34	22.32	15.8
Operating Expenses	249.6	234.12	204.62	184.12	169.75	146.57
Operating Income	21.09	20.02	9.26	17.11	10.55	8.7
Interest Expense	-5.95	-5.56	-3.44	-3.21	-3.26	-2.74
Interest & Investment Income	0.1	0.08	0.03	0.24	0.03	0.02
Currency Exchange Gain (Loss)	-1.84	-2.08	-0.25	-2.43	-2.35	-3.27
Other Non Operating Income (Expenses)	0.3	0.46	0.75	0.27	-0	-
EBT Excluding Unusual Items	13.69	12.91	6.35	11.99	4.97	2.71
Gain (Loss) on Sale of Assets	0.54	0.18	2.81	0.95	0.03	0.21
Asset Writedown	0.6	0.6	1.16	0.6	1.64	3.76
Pretax Income	14.83	13.69	10.32	13.53	6.64	6.69
Income Tax Expense	9.89	2.01	2.82	1.96	2	1.99
Earnings From Continuing Operations	4.94	11.68	7.49	11.57	4.64	4.69
Minority Interest in Earnings	-4.9	-3.96	1.72	-0.84	2.12	2.83
Net Income	0.04	7.72	9.22	10.73	6.75	7.52
Net Income to Common	0.04	7.72	9.22	10.73	6.75	7.52
Net Income Growth	-99.65%	-16.25%	-14.10%	58.86%	-10.23%	-37.93%
Shares Outstanding (Basic)	516	511	511	511	510	510
Shares Outstanding (Diluted)	516	511	511	511	510	510
Shares Change (YoY)	0.90%	-	-	0.30%	-0.00%	-0.18%
EPS (Basic)	0.00	0.02	0.02	0.02	0.01	0.01
EPS (Diluted)	0.00	0.02	0.02	0.02	0.01	0.01
EPS Growth	-99.65%	-16.25%	-14.11%	58.38%	-10.22%	-37.82%
Free Cash Flow	25.96	24.33	11.88	21.53	-20.68	-28.37
Free Cash Flow Per Share	0.05	0.05	0.02	0.04	-0.04	-0.06
Gross Margin	22.81%	22.69%	21.35%	22.66%	22.37%	19.81%
Operating Margin	1.78%	1.79%	0.92%	1.93%	1.31%	1.11%
Profit Margin	0.00%	0.69%	0.92%	1.21%	0.84%	0.96%
Free Cash Flow Margin	2.19%	2.17%	1.19%	2.42%	-2.57%	-3.62%
EBITDA	31.7	36.2	24.18	31.36	25.2	18.89
EBITDA Margin	2.67%	3.23%	2.41%	3.53%	3.13%	2.41%
D&A For EBITDA	10.61	16.18	14.92	14.25	14.65	10.19
EBIT	21.09	20.02	9.26	17.11	10.55	8.7
EBIT Margin	1.78%	1.79%	0.92%	1.93%	1.31%	1.11%
Effective Tax Rate	66.71%	14.69%	27.38%	14.48%	30.15%	29.82%
Revenue as Reported	1,189	1,122	1,005	890.27	810.89	788.92

Source: S&P Capital IQ. Standard template. Financial Sources.